Epidemiology of the dementias: recent developments and new approaches.

[1]  W. McDonald,et al.  Inverse association of anti‐inflammatory treatments and Alzheimer's disease , 1994, Neurology.

[2]  Giovanni B. Frisoni,et al.  Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's disease , 1995 .

[3]  A. Heyman,et al.  Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991 .

[4]  K. Muramoto,et al.  Aluminum Promotes the Aggregation of Alzheimer′s Amyloid β-Protein in Vitro , 1994 .

[5]  S. Sorbi,et al.  ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease , 1994, Neuroscience Letters.

[6]  J. Garcìa,et al.  The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. , 1995, Stroke.

[7]  A. Holland,et al.  Down's syndrome and the links with Alzheimer's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[8]  G. Frisoni,et al.  Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. , 1995, Annals of neurology.

[9]  J. Hooker.  Unnecessary D & Cs , 1995, The Lancet.

[10]  Y. L. Dubreuil,et al.  Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  V. Henderson,et al.  Estrogen deficiency and risk of Alzheimer's disease in women. , 1994, American journal of epidemiology.

[12]  P. Amouyel,et al.  The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease , 1994, The Lancet.

[13]  P. Mölsä,et al.  Long‐term survival and predictors of mortality in Alzheimer's disease and multi‐infarct dementia , 1995, Acta neurologica Scandinavica.

[14]  P. Corey,et al.  Effect of exposure of miners to aluminium powder , 1990, The Lancet.

[15]  B. Dubois,et al.  Clinical spectrum of CADASIL: a study of 7 families , 1995, The Lancet.

[16]  L. Fratiglioni,et al.  Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[17]  P. Lee,et al.  Smoking and Alzheimer's disease: a review of the epidemiological evidence. , 1994, Neuroepidemiology.

[18]  A D Roses,et al.  Apolipoprotein E and Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[20]  Hiromitsu Iwamoto,et al.  Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population , 1995, Neurology.

[21]  J. Copeland,et al.  Alzheimer's Disease, Other Dementias, Depression and Pseudo-dementia: Prevalence, Incidence and Three-Year Outcome in Liverpool , 1992, British Journal of Psychiatry.

[22]  A. Hofman,et al.  The apolipoprotein E ε2 allele is associated with an increased risk of early‐onset alzheimer's disease and a reduced survival , 1995 .

[23]  C. W. Scott,et al.  Aggregation of tau protein by aluminum , 1993, Brain Research.

[24]  C. Clark,et al.  Estimated prevalence of dementia among elderly black and white community residents. , 1991, Archives of neurology.

[25]  J. Lanke,et al.  Prevalence of age psychosis and mortality among age psychotics in the Lundby Study. Changes over time during a 25-year observation period. , 1985, Neuropsychobiology.

[26]  K. Muramoto,et al.  Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. , 1994, Biochemical and biophysical research communications.

[27]  B. Plassman,et al.  Smoking, Alzheimer's disease, and confounding with genes , 1995, The Lancet.

[28]  J. Corwin,et al.  Age-Related Effects of the Nicotinic Antagonist Mecamylamine on Cognition and Behavior , 1994, Neuropsychopharmacology.

[29]  Smoking, Alzheimer's disease, and confounding with genes , 1995, The Lancet.

[30]  I. Skoog.  Risk factors for vascular dementia: a review. , 1994, Dementia.

[31]  L. Fratiglioni,et al.  Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[32]  L. Murray,et al.  Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[33]  C. V. van Duijn,et al.  Epidemiology of the dementias: recent developments and new approaches. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[34]  T. Hasegawa,et al.  Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system , 1994, Pharmacology Biochemistry and Behavior.

[35]  M. Folstein,et al.  Nonsteroidal anti-inflammatory drugs in Alzheimer's disease , 1995, Neurology.

[36]  J. Haines,et al.  The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. , 1995, JAMA.

[37]  D. Carmelli,et al.  Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. , 1994, Archives of neurology.

[38]  L. Thal,et al.  The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease , 1995, Annals of neurology.

[39]  A. Hofman,et al.  Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease , 1995, BMJ.

[40]  G. Schellenberg,et al.  Alzheimer's disease, apolipoprotein E4, and gender. , 1994, JAMA.

[41]  G. Frisoni,et al.  Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease. , 1994, Stroke.

[42]  Yaakov Stern,et al.  Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community‐dwelling elderly persons and their first‐degree relatives , 1993, Annals of neurology.

[43]  L. Fratiglioni,et al.  Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.

[44]  P. Wolf,et al.  Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting? , 1991, Archives of neurology.

[45]  A Hofman,et al.  The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. , 1991, International journal of epidemiology.

[46]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[47]  J. Copeland,et al.  Heavy Drinking as a Risk Factor for Depression and Dementia in Elderly Men , 1991, British Journal of Psychiatry.

[48]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[49]  Daniel B Hier,et al.  Predictors of survival in clinically diagnosed Alzheimer's disease and multi-infarct dementia. , 1989, Archives of neurology.

[50]  A. Mackinnon,et al.  Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample , 1995, The Lancet.

[51]  A Hofman,et al.  Interaction between genetic and environmental risk factors for Alzheimer's disease: A reanalysis of case‐control studies , 1994, Genetic epidemiology.

[52]  P. Dash,et al.  Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid. , 1995, Biochemical and biophysical research communications.

[53]  L. Wilkins.  Is the incidence of dementing illness changing? A 25‐year time trend study in Rochester, Minnesota (1960–1984) , 1994, Neurology.

[54]  A. Hofman,et al.  Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. , 1991, International journal of epidemiology.

[55]  R Doll,et al.  Review: Alzheimer's disease and environmental aluminium. , 1993, Age and ageing.

[56]  KennethRockwood,et al.  The Canadian Study of Health and Aging* , 1994, Neurology.

[57]  M. Albert,et al.  Relation of smoking and alcohol consumption to incident Alzheimer's disease. , 1992, American journal of epidemiology.

[58]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[59]  R. Frackowiak,et al.  Chromosome 14 linked familial Alzheimer's disease. A clinico-pathological study of a single pedigree. , 1995, Brain : a journal of neurology.

[60]  B. Winblad,et al.  Risk factors for late‐ onset Alzheimer's disease: A population‐ based, case‐control study , 1993, Annals of neurology.

[61]  H. Bickel,et al.  Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study , 1994, Psychological Medicine.

[62]  D. Clair,et al.  Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls , 1994, Neuroscience Letters.

[63]  P C O'Brien,et al.  Is the incidence of dementing illness changing? , 1993, Neurology.

[64]  G. Forloni,et al.  Nonsteroidal antiinflammatory drug use in Alzheimer's disease , 1994, Biological Psychiatry.

[65]  A. Hofman,et al.  Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? , 1995, Neurology.

[66]  J. Habbema,et al.  Survival of Patients with Dementia , 1991, Journal of the American Geriatrics Society.

[67]  M. Somerville,et al.  Autoimmune thyroiditis associated with mild "subclinical" hypothyroidism in adults with Down syndrome: a comparison of patients with and without manifestations of Alzheimer disease. , 1990, American journal of medical genetics.

[68]  M A Pericak-Vance,et al.  Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.

[69]  C. V. van Duijn,et al.  A case—control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome , 1995 .

[70]  Bradley T. Hyman,et al.  Reduced apolipoprotein ϵ4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals , 1994, Neurology.

[71]  B. Winblad,et al.  Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. , 1995, Neuroscience letters.

[72]  J. Weissenbach,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 , 1993, Nature Genetics.

[73]  D. Bowen,et al.  The failing brain. , 1983, Journal of chronic diseases.

[74]  R. Katzman.,et al.  Education and the prevalence of dementia and Alzheimer's disease , 1993, Neurology.

[75]  G. Belle,et al.  Relationship between cigarette smoking and Alzheimer's disease in a population‐based case‐control study , 1992, Neurology.

[76]  J. Hardy,et al.  Chromosome 14–encoded Alzheimer's disease: Genetic and clinicopathological description , 1994, Annals of neurology.

[77]  A. Hofman,et al.  Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease , 1994, Nature Genetics.

[78]  Z. Y. Wang,et al.  The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. , 1994, Archives of neurology.

[79]  R. Mayeux,et al.  Cumulative risks of developing extrapyramidal signs, psychosis, or myoclonus in the course of Alzheimer's disease. , 1991, Archives of neurology.

[80]  D. Commenges,et al.  Tobacco consumption and cognitive impairment in elderly people. A population-based study. , 1994, Annals of epidemiology.

[81]  B. Winblad,et al.  Lack of association between apolipoprotein E allele ɛ4 and sporadic Alzheimer's disease , 1994, Neuroscience Letters.

[82]  M. Barón,et al.  [Apolipoprotein E and Alzheimer disease (reply)]. , 1997, Revista clinica espanola.

[83]  R. Mayeux,et al.  Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome , 1994, The Lancet.

[84]  B. Mcdonald,et al.  Absence of aluminium in neuritic plaque cores in Alzheimer's disease , 1992, Nature.

[85]  M. Rossor,et al.  Association between autoimmune thyroid disease and Familial Alzheimers disease , 1991, Clinical endocrinology.

[86]  H. Shimano,et al.  Plasma apolipoproteins in patients with multi-infarct dementia. , 1989, Atherosclerosis.

[87]  L A Beckett,et al.  Age-specific incidence of Alzheimer's disease in a community population. , 1995, JAMA.

[88]  G. Livingston,et al.  The Gospel Oak Study stage III: the incidence of dementia , 1994, Psychological Medicine.

[89]  G. Perry,et al.  Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure , 1992, Journal of the Neurological Sciences.

[90]  K. Morgan,et al.  Incidence of Dementia in a Representative British Sample , 1993, British Journal of Psychiatry.

[91]  P. Barberger‐Gateau,et al.  Components of drinking water and risk of cognitive impairment in the elderly. , 1994, American journal of epidemiology.

[92]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[93]  M. Folstein,et al.  Head injury as a risk factor in Alzheimer's disease. , 1995, Brain injury.

[94]  R B D'Agostino,et al.  The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study , 1995, Neurology.

[95]  J. Buckwalter,et al.  Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. , 1994, Archives of neurology.

[96]  Ellen M. Wijsman,et al.  The Apolipoprotein E E4 Allele and Sex-Specific Risk of Alzheimer's Disease , 1995 .

[97]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[98]  S. Li,et al.  A three‐year follow‐up study of age‐related dementia in an urban area of Beijing , 1991, Acta psychiatrica Scandinavica.

[99]  B T Hyman,et al.  Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. , 1994, Neurology.

[100]  D. Coakley,et al.  Bone aluminium content in Alzheimer's disease. , 1995, Dementia.

[101]  C. Brayne,et al.  Incidence of dementia in a population older than 75 years in the United Kingdom. , 1994, Archives of general psychiatry.

[102]  E. Feskens,et al.  Apolipoprotein e4 allele and cognitive decline in elderly men , 1994, BMJ.

[103]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[104]  S. M. Sumi,et al.  Phenotype of chromosome 14–linked familial Alzheimer's disease in a large kindred , 1994, Annals of neurology.

[105]  R B D'Agostino,et al.  Incidence of dementia and probable Alzheimer's disease in a general population , 1993, Neurology.

[106]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. , 1995, Neurology.

[107]  H. Honjo,et al.  Senile dementia-Alzheimer's type and estrogen. , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[108]  D. Geva,et al.  Dementia. Age-dependent incidence, prevalence, and mortality in the old old. , 1991, Archives of internal medicine.

[109]  J. Growdon,et al.  Rate of progression of Alzheimer's disease is associated with genetic risk. , 1995, Archives of neurology.

[110]  A Hofman,et al.  Cerebral white matter lesions and atherosclerosis in the Rotterdam Study , 1993, The Lancet.

[111]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[112]  A. Brookes,et al.  Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. , 1994, Neuroscience letters.

[113]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[114]  J. Silverman,et al.  A case‐control study of Alzheimer's disease in China , 1992, Neurology.

[115]  D P Forster,et al.  Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. , 1995, Journal of epidemiology and community health.

[116]  K P Offord,et al.  Lack of association between Alzheimer's disease and education, occupation, marital status, or living arrangement , 1992, Neurology.

[117]  M. Mendez,et al.  Risk factors in Alzheimer's disease , 1992, Neurology.

[118]  W. Kukull,et al.  Are There Clinical and Epidemiological Differences between Familial and Non‐familial Alzheimer's Disease? , 1991, Journal of the American Geriatrics Society.

[119]  I. Skoog,et al.  A population-based study of dementia in 85-year-olds. , 1993, The New England journal of medicine.

[120]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[121]  S. M. Sumi,et al.  Myoclonus, Seizures, and Paratonia in Alzheimer Disease , 1990, Alzheimer disease and associated disorders.

[122]  L. Yatham,et al.  Down's syndrome and its association with Alzheimer's disease , 1988, Acta psychiatrica Scandinavica.

[123]  L. Thal,et al.  The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease , 1995, Annals of neurology.

[124]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[125]  E B Larson,et al.  Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. , 1995, American journal of epidemiology.

[126]  D. Morens,et al.  Cigarette smoking and protection from Parkinson's disease , 1995, Neurology.

[127]  G. Schellenberg,et al.  Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans , 1995, Annals of neurology.

[128]  B. Winblad,et al.  Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease. , 1994, Neuroscience letters.

[129]  I. Ferrier,et al.  Effect of silicon on gastrointestinal absorption of aluminium , 1993, The Lancet.

[130]  D. Schaid,et al.  Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.

[131]  J. Haines,et al.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease , 1995, Neurology.

[132]  D. Petitti,et al.  Association of education with reported age of onset and severity of Alzheimer's disease at presentation: implications for the use of clinical samples. , 1993, American journal of epidemiology.

[133]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[134]  A. Mann,et al.  Risk factors for Alzheimer's disease and dementia , 1994, Neurology.

[135]  C. Harrington,et al.  Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients , 1994, The Lancet.

[136]  E. Kokmen,et al.  The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota , 1991, Neurology.

[137]  S. Milham,et al.  Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. , 1994, Lancet.

[138]  J. Morris,et al.  Aphasia, family history, and the longitudinal course of senile dementia of the alzheimer type , 1985, Psychiatry Research.

[139]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[140]  B. Tycko,et al.  Synergistic Effects of Traumatic Head Injury and Apolipoprotein-epsilon4 in Patients With Alzheimer's Disease , 1995, Neurology.

[141]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele ϵ4 with late‐onset Alzheimer's disease among Finnish centenarians , 1995, Neurology.

[142]  B. Tycko,et al.  Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.

[143]  E B Larson,et al.  Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. , 1994, American journal of epidemiology.

[144]  J. Lanke,et al.  Prevalence and incidence of senile and multi-infarct dementia in the Lundby Study: a comparison between the time periods 1947-1957 and 1957-1972. , 1986, Neuropsychobiology.

[145]  J. McCarten,et al.  Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety , 1995, Pharmacology Biochemistry and Behavior.

[146]  L. Kurland,et al.  Rheumatoid arthritis and susceptibility to Alzheimer's disease , 1991, The Lancet.

[147]  D Commenges,et al.  Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. , 1994, International journal of epidemiology.

[148]  G. Fasman,et al.  Solubilization of beta-amyloid-(1-42)-peptide: reversing the beta-sheet conformation induced by aluminum with silicates. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[149]  B. Winblad,et al.  Apolipoprotein ϵ4 allele and disease progression in patients with late-onset Alzheimer's disease , 1995, Neuroscience Letters.

[150]  A. Alpérovitch,et al.  Absence of familial association between dementia of Alzheimer type and Down syndrome. , 1989, American journal of medical genetics.

[151]  D. Carmelli,et al.  Lower Cognitive Performance in Normal Older Adult Male Twins Carrying the Apolipoprotein E ε4 Allele , 1994 .

[152]  L. Barregard,et al.  Long-term follow up of workers exposed to solvents. , 1990, British journal of industrial medicine.

[153]  R. Ravid,et al.  ‘Lewy body disease’: clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia , 1995, Clinical Neurology and Neurosurgery.

[154]  Yaakov Stern,et al.  Increased risk of mortality in alzheimer's disease patients with more advanced educational and occupational attainment , 1995, Annals of neurology.

[155]  F. Mcdowell,et al.  Risk Factors in Alzheimer’s Disease , 1986 .

[156]  L. Nilsson.  Incidence of severe dementia in an urban sample followed from 70 to 79 years of age , 1984, Acta psychiatrica Scandinavica.

[157]  P. O'Brien,et al.  Are patients with Alzheimer's disease surviving longer in recent years? , 1994, Neurology.

[158]  A. Hofman,et al.  Epidemiology of Alzheimer's disease. , 1992, Epidemiologic reviews.